Lyell Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
VCM
VPM
Lyell Wealth Management's ABBV Position: Q1 2026 in Review
Lyell Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 1,968 shares worth $428K. The position accounts for 0.03% of the portfolio, ranked #164.
Lyell Wealth Management first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. The position peaked at $450K in Q4 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Lyell Wealth Management held 1,968 shares of AbbVie worth $428K as of Q1 2026.
- Lyell Wealth Management left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 0.03% of Lyell Wealth Management's portfolio in Q1 2026, its #164 holding.
- Lyell Wealth Management first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
- Lyell Wealth Management's AbbVie position peaked at $450K in Q4 2025.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Lyell Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.